Posts Tagged ‘treatment’
Proteonomix, Inc., a biotechnology company, engages in the development of stem cell therapies primarily for the treatment of diabetes and cardiac therapy, as well as offers cosmeceutical products. The stem cell therapy involves the …
Hiring Company: YOHJob Code: Temporary Research ScientistLocation: San Diego CountyJob Type: Contract – 1 yearDescription: Summarized Role Description: The.
Environmental Biotechnology Rapidshare Downloads. This book shows people how to create an eco-friendly garden from scratch or by redeveloping an existing garden
ACT Biotech’s Telatinib receives orphan drug designation from FDA for treatment of gastric cancer
3 Jun 2010ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, announced today that the company’s highly selective oral kinase inhibitor, Telatinib, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of gastric cancer.
Researchers testing a vaginal microbicide based on a new type of anti-HIV drug found it provided monkeys significant protection against infection with a virus similar to HIV. The study is the first of a gel with an integrase inhibitor, one of the latest additions to the arsenal of drugs for the treatment of HIV but just one of the many compounds researchers hope will be a stronghold for HIV prevention.
ImmunoCellular Therapeutics, a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that the Company and Torrey Pines Institute for Molecular Studies in San Diego, CA have identified several peptides which can generate CD-133 specific T-cells. CD-133 is found in high abundance on cancer stem cells (“CSCs …
Fibrocell Science, Inc, a biotechnology company focusing on the development of autologous cell therapies for aesthetic, medical and scientific applications, has initiated a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the US Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.
Kyto Biopharma Inc. (OTCBB: KBPH), is a Florida biotechnology company focused on developing monoclonal antibody and oligonucleotide targeting therapeutics based on a proprietary vitamin B12 platform for the treatment of various forms of cancer.
About Biolexis
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.
Biotech
Categories
- Biotechnology News (4750)
Archives
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- December 2008
- November 2008
- October 2008
- August 2008
- July 2008
- June 2008
- April 2008
- February 2008
- January 2008
- December 2007
- August 2007
- July 2007
- June 2007
- April 2007
- February 2007
- December 2006
- September 2006
- August 2006
- New type of anti-malarial compound discovered
- Mechanisms and function of a type of mysterious immune cell discovered
- Molecules involved in ‘touch’ identified: Could lead to new treatments for pain, deafness and cardiac function
- Why fish oils work swimmingly against inflammation and diabetes
- Scientists unwrap DNA packaging to gain insight into cells
- Nanobiotechnology advances point to medical applications
- Generex Biotechnology Initiates Social Media Campaign for Its Corporate and e-Commerce Websites
- Lima beans domesticated twice
- Commercial organic farms have better fruit and soil, lower environmental impact, study finds
- Live imaging puts new light on stem cell division
